Home
/
Coya Therapeutics, Inc.
/
Financials
/
Quarterly
Coya Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Coya Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.56M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$163.6K
Aug 12, 2025
Q1
2025
Mar 31, 2025
$257.9K
May 13, 2025
Q3
2024
Sep 30, 2024
$0
Nov 6, 2024
Q2
2025
Jun 30, 2024
$3.43M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$126.8K
May 13, 2025
Q3
2024
Sep 30, 2023
$0
Nov 6, 2024
Q2
2024
Jun 30, 2023
$0
Aug 12, 2024
Q1
2024
Mar 31, 2023
$0
May 9, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.12M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($6.09M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($6.09M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($7.31M)
May 13, 2025
Q2
2025
Mar 31, 2025
($7.31M)
Aug 12, 2025
Q3
2025
Mar 31, 2025
($7.31M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($4.02M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($2.89M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($2.89M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($5.05M)
May 13, 2025
Q2
2025
Mar 31, 2024
($5.05M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($5.05M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($3.42M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($3.10M)
Aug 12, 2024
Q3
2024
Jun 30, 2023
($3.10M)
Nov 6, 2024
Q3
2024
Mar 31, 2023
($2.74M)
Nov 6, 2024
Q1
2024
Mar 31, 2023
($2.74M)
May 9, 2024
Q2
2024
Mar 31, 2023
($2.74M)
Aug 12, 2024
Q3
2023
Sep 30, 2022
($4.02M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($3.41M)
Aug 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.43M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($6.41M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($7.68M)
May 13, 2025
Q3
2025
Sep 30, 2024
($4.45M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($3.24M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($5.48M)
May 13, 2025
Q3
2024
Sep 30, 2023
($3.56M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($3.25M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($2.90M)
May 9, 2024
Q3
2023
Sep 30, 2022
($2.66M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($3.45M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($1.70M)
May 10, 2023